Notice of Annual General Meeting

Summary by AI BETAClose X

Wellnex Life Limited has announced the Notice of Meeting and associated documentation for its Annual General Meeting (AGM) to be held on November 30, 2026, at 10:00 a.m. Melbourne time. The full notice and explanatory memorandum are available on the company's website.

Disclaimer*

Wellnex Life Limited
29 October 2026
 

 

 ASX/AIM Announcement        

                                                                                                            29 October 2026

Notice of Annual General Meeting

Wellnex Life Limited (ASX/AIM: WNX) ("Wellnex Life" or the "Company") announces that it has today published and submitted to the Australian Securities Exchange the formal Notice of Meeting and associated documentation in respect of its Annual General Meeting ("AGM") to be held at 10.00 a.m. (Melbourne time) on 30 November 2026 at the offices of Thomsons, Level 23, Rialto South Tower, 525 Collins Street, Melbourne VIC 3000 Australia.

 

A copy of the full Notice of Meeting and explanatory memorandum is available on the Company's website at www.wellnexlife.com.au/

 

This ASX/AIM announcement has been authorised by the Board of Wellnex Life Limited (ASX/AIM:WNX).

--- END ---

For further information, please contact:

Wellnex Life Limited (ASX/AIM:WNX)                

Eric Jiang                                                        

Interim Executive Chairman                                           

E: eric.j@wellnexlife.com.au    

 

UK Investors

Strand Hanson (Financial & Nominated Advisor)

James Harris / Richard Johnson                                     Tel: +44 (0) 20 7409 3494

 

Orana Corporate LLP (Joint Broker)                                swykeham@oranacorp.com

Sebastian Wykeham    

 

S.P. Angel Corporate Finance LLP (Joint Broker)            Tel: +44 (0)20 3470 0470

David Hignell / Vadim Alexandre

 

To learn more, please visit: https://wellnexlife.com.au/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings